What is the elimination half-life of methadone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Methadone Half-Life: 15-120 Hours with Average of 24 Hours

Methadone has a highly variable elimination half-life ranging from 15 to 120 hours, with an average of approximately 24 hours 1. This marked interindividual variability is one of methadone's most clinically significant characteristics and directly impacts dosing strategies.

Key Pharmacokinetic Properties

The FDA drug label specifies that methadone's plasma elimination half-life typically ranges from 8 to 59 hours 2, though clinical guidelines cite the broader range of 15-120 hours 1. For the active (R)-enantiomer specifically, mean values around 40 hours have been documented 3.

Critical Clinical Implications

The discrepancy between methadone's analgesic duration (4-8 hours) and its elimination half-life creates significant risk for drug accumulation 2. This mismatch means:

  • Steady-state plasma concentrations are not reached until 3-5 days of dosing 2
  • In some individuals, steady state may take several days to 2 weeks 1
  • Peak respiratory depressant effects occur later and persist longer than peak analgesic effects 2
  • The drug accumulates with repeated dosing, requiring dosing intervals no more frequent than every 8 hours 4

Factors Affecting Half-Life Variability

Drug Interactions

CYP450 enzyme inducers and inhibitors significantly alter methadone half-life 5:

  • Inducers (rifampin, phenobarbital, phenytoin, carbamazepine, nevirapine, efavirenz) decrease methadone concentrations and shorten half-life, potentially causing withdrawal 3
  • Inhibitors (fluconazole, paroxetine) increase methadone concentrations and prolong half-life 3

Pregnancy

Pregnancy substantially shortens methadone half-life due to CYP450 enzyme induction and increased volume of distribution 2. One case report documented a half-life as short as 9.22 hours in a postpartum patient requiring 900 mg daily 6.

Hepatic Function

Methadone is metabolized primarily by hepatic pathways (CYP3A4, CYP2B6, CYP2C19), so patients with liver impairment risk drug accumulation despite the same dosing interval 2.

Clinical Monitoring Requirements

Because of the long and variable half-life, observe for drug accumulation and adverse effects especially over the first 4-5 days 1. The NCCN guidelines emphasize that methadone should not be titrated more frequently than every 5-7 days 1.

Warning Signs

Any significant sedation or marked pain improvement before day 5 indicates the dose may be too high, placing the patient at risk for oversedation or respiratory depression by days 5-7 if not immediately adjusted 1.

Dosing Implications

The long half-life necessitates:

  • Initial dosing should not exceed 30-40 mg on day 1 2
  • Methadone is typically dosed every 8-12 hours for chronic pain 1
  • Some patients with rapid metabolism may require three times daily dosing to maintain therapeutic levels 6
  • Deaths have occurred in early treatment due to cumulative effects from the first several days' dosing 2

Common Pitfall

The most dangerous error is failing to account for methadone's delayed accumulation. Providers may be tempted to increase doses too quickly when patients report inadequate analgesia in the first 3-4 days, not recognizing that steady state has not yet been achieved. Wait at least 5-7 days between dose adjustments 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.